Cygnal Therapeutics

We are a @FlagshipPioneer company developing drugs in the field of #exoneuralbiology, starting with cancer and inflammatory diseases.

[Prof Linda Gay Griffith @LindaGGriffith1]

Scientist position at a cool Cambridge company, Cygnal Therapeutics. Nerve-tissue interactions, in endometriosis! Get industry pay while having the fun of a postdoc position, working with both the amazing Cygnal folks, and my lab. https://t.co/quWo2zzJrz

[Cygnal Therapeutics @cygnaltx]

We're looking for enthusiastic and entrepreneurially-minded immunologists and neuroscientists to join our dynamic team. Help us advance the promise of exoneural biology—check out our open roles and apply today! https://t.co/dkdj26DrdY #TeamCygnal #ExoneuralBiology

[Cygnal Therapeutics @cygnaltx]

ICYMI: @Cygnaltx CEO Pearl Huang spoke at a recent @BosBizJournal event about women and life science careers. Read @BosBizRowan’s feature for insights from 7 local leaders, including Pearl. https://t.co/sxr6lZBLMW #BBJLIFESCIENCES

[Cygnal Therapeutics @cygnaltx]

Congratulations to Drs. Julius and Patapoutian! This is a new frontier of science, and we use these laureates' fundamental discoveries daily in Cygnal's labs. It's exciting to see this recognition for their research into the important roles neurons play in the human body.

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The 2021 #NobelPrize in Physiology or Medicine has been awarded jointly to David Julius and Ardem Patapoutian “for their discoveries of receptors for temperature and touch.”

[Cygnal Therapeutics @cygnaltx]

A big congratulations to @michelle_monje on receiving a @macfound genius grant! Michelle conducts ground-breaking research into #CancerNeuroscience. It's a privilege to have her on our SAB. https://t.co/tpkXShIyXD

[Cygnal Therapeutics @cygnaltx]

On October 7, our CEO Pearl Huang will speak at the @BosBizJournal's Women Who Lead in Life Sciences event. Come hear her insights on leadership, the role of a CEO, and more! https://t.co/SF5V53gsnF #BBJLIFESCIENCES

[Cygnal Therapeutics @cygnaltx]

Next month, @Cygnaltx CEO Pearl Huang will speak at the Longwood Healthcare Leaders meeting about advancing platform technologies alongside leaders from @Synlogic_Tx, @Rubius_tx, @TakedaPharma, and @TectonicTx. Register to attend and hear their insights. https://t.co/Vp1sf3lskD

[Cygnal Therapeutics @cygnaltx]

@charlesriver Thanks for having us—we enjoyed the day!

[Cygnal Therapeutics @cygnaltx]

Job alert: We're looking for a Principal Scientist of Protein Chemistry & Protein Analysis. If you're interested in joining a collaborative team, apply online today! https://t.co/24ezcupVKJ

[Cygnal Therapeutics @cygnaltx]

Our team recently volunteered with the Charles River Watershed Association (@charlesriver) to clean up invasive water chestnuts from the river. We had a great time having fun and helping our community!

[Cygnal Therapeutics @cygnaltx]

Want to join an interdisciplinary team of 50+ inquiring scientists? We're hiring for several open roles. Take a look at our website and apply! https://t.co/dkdj26DrdY

[Cygnal Therapeutics @cygnaltx]

John Hohneker, M.D., an experienced leader in biotech and pharma, has joined @Cygnaltx's Board of Directors. John most recently served as the CEO of Anokion between January 2018 and January 2021. Welcome, John! https://t.co/k2Z3W727HE

[Cygnal Therapeutics @cygnaltx]

Later this month, our CEO Pearl Huang will speak on a panel about mentorship, leadership, and other challenges in #biotech R&D. Sign up to attend and hear her thoughts! https://t.co/PgYQwD0sb6

[Cygnal Therapeutics @cygnaltx]

Cygnal’s Scientific Advisory Board is a group of extraordinary scientists and researchers. We're pleased to share that Jennifer Petter, Ph.D., cofounder/CSO of @ArrakisTx, has joined our SAB. Learn more about Jennifer on our website. https://t.co/Yc589dT863

[Cygnal Therapeutics @cygnaltx]

Timothy Zheng, Ph.D., has joined @cygnaltx as SVP of Biology. Tim brings two decades of extensive experience in drug discovery and development to the team. Welcome to Cygnal, Tim! https://t.co/MX8HmgiJGE

[Cygnal Therapeutics @cygnaltx]

Check out the June issue of @PharmaVOICE to learn about trends and challenges facing chief medical officers today, including thoughts from @Cygnaltx CMO John Wagner. https://t.co/r0eMeHYMiR

[Cygnal Therapeutics @cygnaltx]

Interested in the bioplatform approach to life science innovation? @FlagshipPioneer's @GVMaltzahn shares thoughts on the benefits, different types, and future of platforms. https://t.co/moQy5OV2Sx #Bioplatforms #Biotechnology #FlagshipPioneering

[Cygnal Therapeutics @cygnaltx]

Missed our CEO Pearl Huang at the @endpts R&D summit? No problem—view the panel on demand to hear her perspective alongside insights from leaders at @AstraZeneca, Johnson & Johnson, @Pfizer, and @sanofi. https://t.co/vOKfOyts0s #BIO21 #Biotechnology #BIODigital

[Noubar Afeyan @NoubarAfeyan]

Glad to see Boston getting the recognition it deserves as biotech’s equivalent of Silicon Valley. The best is yet ahead for the region, for our biotech industry, and for its impacts on human health and sustainability.
https://t.co/fljrUetYsa @BostonGlobe @ScottKirsner

[Cygnal Therapeutics @cygnaltx]

A big congratulations to our founder, Flagship Pioneering!

[Flagship Pioneering @FlagshipPioneer]

Today we announced that Flagship has closed a $3.4 billion capital pool to fuel its unbounded pursuit of scientific advances that reimagine how to prevent and treat disease, feed a growing population, and sustain our planet. Read more: https://t.co/AFxEXY9tFK